Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Alrizomadlin by Ascentage Pharma Group International for Adenoid Cystic Carcinoma (ACC): Likelihood of Approval
Alrizomadlin is under clinical development by Ascentage Pharma Group International and currently in Phase II for Adenoid Cystic Carcinoma (ACC)....